Our website is made possible by displaying non-intrusive online advertisements to our visitors.
Please consider supporting us by disabling or pausing your ad blocker.
KUALA LUMPUR: Alpha IVF Group Bhd terus memperkukuh kehadirannya di Indonesia dengan pembukaan klinik satelit Medan, sekali gus menandakan bandar ketiga operasinya di negara jiran itu selepas Jakarta dan Surabaya.
Alpha IVF Group's satellite clinic model allows the group to detect early demand, strengthen patient engagement, and channel referrals to the core IVF treatment centers in Malaysia without the need for high capital investment.
Alpha IVF Founder Signals Strong Confidence as "Intention to Deal" Suggests Significant Undervaluation?
In a move that serves as a massive vote of confidence for shareholders, Dato’ Dr. Lee Soon Soo, the Managing Director of Alpha IVF Group Berhad, has officially signalled his intention to trade company securities during the current Closed Period (the restricted window preceding financial results).
While "Dealing During a Closed Period" is a regulatory requirement under Chapter 14 of the Listing Requirements, it is rarely utilized unless an insider sees a critical opportunity to accumulate shares.
Why This Is a Major Bullish Signal:
- Buying the Discount: Dato' Dr. Lee already controls a dominant 44.45% stake (2.16 billion shares) in the company. When a founder who already holds nearly half the company signals an intent to deal even more, it is a classic indicator that the person believes the market is currently mispricing the stock.
- The "Closed Period" Urgency: Most directors wait for the open period to avoid the transparency of a public declaration. By announcing his intent to deal now; just as the company prepares its latest financial data, it suggests he views the current share price as too attractive to ignore, even for a few weeks.
- Skin in the Game: The filing reveals a deeply entrenched commitment, with interests spread across his direct holdings, his investment vehicle (ACE Specialists Sdn Bhd), and his immediate family. This isn't just a corporate move; it’s a personal bet on the company’s growth trajectory.
- Market Transparency: By complying with the Companies Act 2016 and providing a granular breakdown of his holdings, the MD is signalling total transparency, which historically bolsters investor confidence and reinforces the "Strong Buy" sentiment from the top.
When the man who built, the company is looking to increase his exposure while the rest of the market is waiting for news, it is a loud and clear message: Alpha IVF is currently undervalued.
Alpha IVF Group Berhad announced that its Managing Director, Dato’ Dr Lee Soon Soo, plans to deal in the company’s shares during the closed period, in line with Bursa requirements. He holds approximately 35.1% direct and 9.3% deemed interest, highlighting continued insider commitment and transparency.
